Science Explorer Back to mapMap
Discussion
Company · Louisville · United States

ApoVax (United States)

apovax.comROR OpenAlex
Research works
8
▲ 35% vs 2018-21
Citations
112
14.2 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
29%
world 40%
International
34%
world 18%
ApoVax (United States)

Not ranked overall: ApoVax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ApoVax (United States) work in?

In all years, 44% of research at ApoVax (United States) is in Life Sciences, 28% in Physical Sciences. Its largest fields are Medicine (24%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (20%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 44.4% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 20.2% of its workMolecular Biology: 1 fractional works · 8.9% of its workClinical Biochemistry: 0 fractional works · 6.3% of its workBiophysics: 0 fractional works · 2.2% of its workBiotechnology: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 1.0% of its workEndocrinology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 2 fractional works · 19.9% of its workImmunology: 2 fractional works · 19.9% of its workAgricultural and Biological Sciences: 0 fractional works · 3.3% of its workSoil Science: 0 fractional works · 1.6% of its workAgronomy and Crop Science: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 1.0% of its workPhysical Sciences: 2 fractional works · 28.4% of its workComputer Science: 1 fractional works · 16.9% of its workInformation Systems: 1 fractional works · 12.7% of its workArtificial Intelligence: 0 fractional works · 4.2% of its workMaterials Science: 0 fractional works · 6.3% of its workGeneral Materials Science: 0 fractional works · 2.2% of its workMaterials Chemistry: 0 fractional works · 2.2% of its workSurfaces, Coatings and Films: 0 fractional works · 2.2% of its workEnvironmental Science: 0 fractional works · 2.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.4% of its workPollution: 0 fractional works · 1.4% of its workEngineering: 0 fractional works · 1.4% of its workAutomotive Engineering: 0 fractional works · 1.4% of its workMathematics: 0 fractional works · 1.0% of its workStatistics and Probability: 0 fractional works · 1.0% of its workHealth Sciences: 2 fractional works · 24.5% of its workMedicine: 2 fractional works · 23.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 6.3% of its workEpidemiology: 0 fractional works · 6.3% of its workOncology: 0 fractional works · 4.8% of its workPhysiology: 0 fractional works · 2.2% of its workHematology: 0 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.8% of its workSmall Animals: 0 fractional works · 0.8% of its workSocial Sciences: 0 fractional works · 2.7% of its workBusiness, Management and Accounting: 0 fractional works · 0.9% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.9% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.9% of its workDevelopment: 0 fractional works · 0.9% of its workALL ITS WORKApoVax (UnitedStates)8fractional works, all years
Life Sciences44%Physical Sciences28%Health Sciences24%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology220.2%
    2. Immunology and Microbiology219.9%
    3. Agricultural and Biological Sciences03.3%
    4. Pharmacology, Toxicology and Pharmaceutics01.0%
    1. Computer Science116.9%
    2. Materials Science06.3%
    3. Environmental Science02.8%
    4. Engineering01.4%
    5. Mathematics01.0%
    1. Medicine223.7%
    2. Veterinary00.8%
    1. Business, Management and Accounting00.9%
    2. Economics, Econometrics and Finance00.9%
    3. Social Sciences00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.87× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.02× its world share, 0 worksBiochemistry, Geneti…Engineering: 0.55× its world share, 0 worksEngineeringEnvironmental Science: 3.31× its world share, 0 worksEnvironmental ScienceMedicine: 1.54× its world share, 0 worksMedicineVeterinary: 30.29× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 30.3×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Veterinary30.29×0 works
  2. Biochemistry, Genetics and Molecular Biology7.02×0 works
  3. Environmental Science3.31×0 works
  4. Medicine1.54×0 works
  5. Agricultural and Biological Sciences0.87×0 works
  6. Engineering0.55×0 works

What are the most cited papers from ApoVax (United States)?

The most cited paper from ApoVax (United States) is "4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines" (Rajesh Kumar Sharma, Rich-Henry Schabowsky, Abhishek K. Srivastava et al., 2010), with 58 citations. Next come "A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity" (55) and "SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model" (39).

Most cited papers
#PaperReleasedCitations
1 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines Rajesh Kumar Sharma, Rich-Henry Schabowsky, Abhishek K. Srivastava et al. · Cancer Research Open access 20 Apr 2010 58
2 A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity Rich-Henry Schabowsky, Kutlu G. Elpek, Shravan Madireddi et al. · Vaccine Open access 16 Oct 2009 55
3 SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model Rajesh Kumar Sharma, Abhishek K. Srivastava, Esma S. Yolcu et al. · Vaccine Open access 7 Jul 2010 39
4 Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner Abhishek K. Srivastava, Rajesh Kumar Sharma, Esma S. Yolcu et al. · PLoS ONE Open access 8 Nov 2012 27
5 Primary Tumor Cells Resected from Cancer Patients and Decorated with a Novel Form of CD80 Protein Serve as Effective Antigen-Presenting Cells for the Induction of Autologous T Cell Immune Responses Ex Vivo Narendra Prasad Singh, Robert W. Miller, Esma S. Yolcu et al. · Human Gene Therapy Mar 2006 10
All 6 most cited papers, with filters and sorting

Which research topics does ApoVax (United States) publish most on?

By volume in 2022-now: Cell Image Analysis Techniques, Molecular Biology Techniques and Applications, Spaceflight effects on biology and Escherichia coli research studies.

Cell Image Analysis Tech…0Cell Image Analysis Techniques: 0 fractional worksMolecular Biology Techni…0Molecular Biology Techniques and Applications: 0 fractional worksSpaceflight effects on b…0Spaceflight effects on biology: 0 fractional worksEscherichia coli researc…0Escherichia coli research studies: 0 fractional worksDiabetes and associated disorders: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksBrucella: diagnosis, epi…0Brucella: diagnosis, epidemiology, treatment: 0 fractional worksBlood groups and transfusion: 0 fractional worksVehicle emissions and performance: 0 fractional worksAir Quality and Health I…0Air Quality and Health Impacts: 0 fractional works
BiophysicsMolecular BiologyPhysiologyEndocrinology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cell Image Analysis Techniques Biophysics 0 works
  2. 2 Molecular Biology Techniques and Applications Molecular Biology 0 works
  3. 3 Spaceflight effects on biology Physiology 0 works
  4. 4 Escherichia coli research studies Endocrinology 0 works
  5. 5 Diabetes and associated disorders Genetics 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Brucella: diagnosis, epidemiology, treatment Small Animals 0 works
  8. 8 Blood groups and transfusion Hematology 0 works
  9. 9 Vehicle emissions and performance Automotive Engineering 0 works
  10. 10 Air Quality and Health Impacts Health, Toxicology and Mutagenesis 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.7%not open71.3%

World: 40% of research is openly available.

with international co-authors33.9%domestic only66.1%

World: 18% is written across borders.

How has ApoVax (United States)'s research output changed?

Output in 2022-2025 was 35% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ApoVax (United States) as a percentage of every work published that year, 0.000024% in 2018.

still counting0.000050%0.00010%ApoVax (United States)0.000023% in 202519801990200020102020

Fractional works of ApoVax (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Louisville

All research institutions in Louisville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ApoVax (United States). Posts are plain text and can be reported.